Tissue-specific glucocorticoid signaling may determine the resistance against glucocorticoids in autoimmune diseases

Current Medicinal Chemistry

Volumn 22, Issue 9, 2015, Pages 1126-1135

  Szappanos, A ^a,b   Nagy, Z ^b,c   Kovacs B ^d   Poor G ^a,b   Toth M ^b   Racz K ^b   Kiss, E ^a,b   Patocs A ^b,c  

^a NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^d SZENT ISTVÁN UNIVERSITY   (Hungary)

Author keywords

11 Hydroxysteroid dehydrogenase enzyme; Autoimmune diseases; Glucocorticoid receptor

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; HORMONE; STEROID;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; CELLS BY BODY ANATOMY; CLINICAL FEATURE; ENZYME ACTIVITY; GENETIC VARIABILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INNATE IMMUNITY; PERSONALIZED MEDICINE; PREDICTION; PROTEIN EXPRESSION; SYNOVITIS;

EID: 84931287732     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666141216125012     Document Type: Article

References (82)

1. Cooper, M.S. Glucocorticoids in bone and joint disease: The good, the bad and the uncertain. Clin. Med., 2012, 12(3), 261-265.
2. Raza, K.; Hardy, R.; Cooper, M.S. The 11beta-hydroxysteroid dehydrogenase enzymes-arbiters of the effects of glucocorticoids in synovium and bone. Rheumatology (Oxford), 2010, 49, 2016-2023.
3. Seibel, M.J.; Cooper, M.S.; Zhou, H. Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives. Lancet Diabetes Endocrinol., 2013, 1(1), 59-70.
4. Oakley, R.H.; Cidlowski, J.A. Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem., 2011, 286, 3177-3184.
5. van Rossum, E.F.; van den Akker, E.L. Glucocorticoid resistance. Endocr. Dev., 2011, 20, 127-136.
6. Dekker, M.J.; Tiemeier, H.; Luijendijk, H.J.; Kuningas, M.; Hofman, A.; de Jong, F.H.; Stewart, P.M.; Koper, J.W.; Lamberts, S.W. The effect of common genetic variation in 11β-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression. J. Clin. Endocrinol. Metab., 2012, 97, E233-E237.
7. Beck, I.M.; Vanden Berghe, W.; Vermeulen, L.; Yamamoto, K.R.; Haegeman, G.; De Bosscher, K. Crosstalk in Inflammation: The Interplay of Glucocorticoid Receptor-Based Mechanisms and Kinases and Phosphatases. Endocr. Rev., 2009, 30, 830-882.
8. Turnbull, A.V.; Rivier, C.L. Regulation of the hypothalamicpituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev., 1999, 79, 1-71.
9. Besedovsky, H.O.; del Rey, A. The cytokine-HPA axis feed-back circuit. Z Rheumatol., 2000, 59, 26-30.
10. Hardy, R.S.; Raza, K.; Cooper, M.S. Endogenous glucocorticoids in inflammation: contributions of systemic and local responses. Swiss Med Wkly., 2012, 142, 13650.
11. Besedovsky, H.O.; del Rey, A. Regulating inflammation by glucocorticoids. Nat. Immunol., 2006, 7, 537.
12. Marni, N.; Silverman, B.; Pearce, B.D.; Biron, C.A.; Miller, A.H. Immune Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis during Viral Infection. Viral Immunol., 2005, 18, 41-78.
13. Emptoz-Bonneton, A.; Crave, J.C.; LeJeune, H.; Brebant, C.; Pugeat, M. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells. J. Clin. Endocrinol. Metab., 1997, 82, 3758-3762.
14. Busillo, J.M.; Cidlowski, J.A. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol. Metab., 2013, 24(3), 109-119.
15. Busillo, J.M.; Azzam, K.M.; Cidlowski, J.A. Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome. J. Biol. Chem., 2011, 286, 38703-38713.
16. Hermoso, M.A.; Matsuguchi, T.; Smoak, K.; Cidlowski, J.A. Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression. Mol. Cell. Biol., 2004, 24, 4743-4756.
17. Elenkov, I.J.; Chrousos, G.P. Stress Hormones, Th1/Th2 patterns, Pro/Anti-inflammatory Cytokines and Susceptibility to Disease. Trends Endocrinol. Metab., 1999, 10, 359-368.
18. Franchimont, D.; Galon, J.; Gadina, M.; Visconti, R.; Zhou, Y.; Aringer, M.; Frucht, D.M.; Chrousos, G.P.; O'Shea, J.J. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J. Immunol., 2000, 164, 1768-1774.
19. Sternberg, E.M. Neuroendocrine regulation of autoimmune/ inflammatory disease. J. Endocrinol., 2001, 169, 429-435.
20. Liberman, A.C.; Antunica-Noguerol, M.; Ferraz-de-Paula, V.; Palermo-Neto, J.; Castro, C.N.; Druker, J.; Holsboer, F.; Perone, M.J.; Gerlo, S.; De Bosscher, K.; Haegeman, G.; Arzt, E. Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells. PLoS One, 2012, 7, 35155.
21. Vacchio, M.S.; Ashwell, J.D. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med., 1997, 185, 2033-2038.
22. Nuotio-Antar, A.M.; Hasty, A.H.; Kovacs, W.J. Quantitation and cellular localization of 11beta-HSD1 expression in murine thymus. J. Steroid Biochem. Mol. Biol., 2006, 99, 93-99.
23. Szatmari, I.; Nagy, L. Nuclear receptor signaling in dendritic cells connects lipids, the genome and immune function. EMBO J., 2008, 27, 2353-2362.
24. Freeman, L.; Hewison, M.; Hughes, S.V.; Evans, K.N.; Hardie, D.; Means, T.K.; Chakraverty, R. Expression of 11beta-hydroxysteroid dehydrogenase type 1 permits regulation of glucocorticoid bioavailability by human dendritic cells. Blood, 2005, 106, 2042-2049.
25. Abe, M.; Thomson, A.W. Influence of immunosuppressive drugs on dendritic cells. Transpl. Immunol., 2003, 11, 357-365.
26. Weitnauer, M.; Schmidt, L.; Ng Kuet Leong, N.; Muenchau, S.; Lasitschka, F.; Eckstein, V.; Hübner, S.; Tuckermann, J.; Dalpke A.H. Bronchial epithelial cells induce alternatively activated dendritic cells dependent on glucocorticoid receptor signaling. J. Immunol., 2014, 193, 1475-1484.
27. Grohmann, U.; Volpi, C.; Fallarino, F.; Bozza, S.; Bianchi, R.; Vacca, C.; Orabona, C.; Belladonna, M.L.; Ayroldi, E.; Nocentini, G.; Boon, L.; Bistoni, F.; Fioretti, M.C.; Romani, L.; Riccardi, C.; Puccetti, P. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat. Med., 2007, 13, 579-586.
28. Tomlinson, J.W.; Walker, E.A.; Bujalska, I.J.; Draper, N.; Lavery, G.G.; Cooper, M.S.; Hewison, M.; Stewart, P.M. 11Betahydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response. Endocr. Rev., 2004, 25, 831-866.
29. Chapman, K.E.; Coutinho, A.E.; Gray, M.; Gilmour, J.S.; Savill, J.S.; Seckl, J.R. The role and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in the inflammatory response. Mol. Cell. Endocrinol., 2009, 301, 123-131.
30. Thieringer, R.; Le Grand, C.B.; Carbin, L.; Cai, T.Q.; Wong, B.; Wright, S.D.; Hermanowski-Vosatka, A. 11 Beta-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J. Immunol., 2001, 167, 30-35.
31. Martinez, F.O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol., 2006, 177, 7303-7311.
32. Zhang, T.Y.; Ding, X.; Daynes, R.A. The expression of 11 betahydroxysteroid dehydrogenase type I by lymphocytes provides a novel means for intracrine regulation of glucocorticoid activities. J. Immunol., 2005, 174, 879-889.
33. Bryndová, J.; Zbánková, S.; Kment, M.; Pácha, J. Colitis upregulates local glucocorticoid activation and down-regulates inactivation in colonic tissue. Scand. J. Gastroenterol., 2004, 39, 549-553.
34. Zbánková, S.; Bryndová, J.; Leden, P.; Kment, M.; Svec, A.; Pácha, J. 11beta-hydroxysteroid dehydrogenase 1 and 2 expression in colon from patients with ulcerative colitis. J. Gastroenterol. Hepatol., 2007, 22, 1019-1023.
35. Cooper, M.S.; Kriel, H.; Sayers, A.; Fraser, W.D.; Williams, A.M.; Stewart, P.M.; Probert, C.S.; Tobias, J.H. Can 11β-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease? Calcif. Tissue Int., 2011, 89, 246-251.
36. Tetsuka, M.; Thomas, F.J.; Thomas, M.J.; Anderson, R.A.; Mason, J.I.; Hillier, S.G. Differential expression of messenger ribonucleic acids encoding 11beta-hydroxysteroid dehydrogenase types 1 and 2 in human granulosa cells. J. Clin. Endocrinol. Metab., 1997, 82, 2006-2009.
37. Sai, S.; Nakagawa, Y.; Yamaguchi, R.; Suzuki, M.; Sakaguchi, K.; Okada, S.; Seckl, J.R.; Ohzeki, T.; Chapman, K.E. Expression of 11beta-hydroxysteroid dehydrogenase 2 contributes to glucocorticoid resistance in lymphoblastic leukemia cells. Leuk. Res., 2011, 35, 1644-1648.
38. Kino, T.; Su, Y.A.; Chrousos, G.P. Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology. Cell. Mol. Life Sci., 2009, 66, 3435-3448.
39. Ratman, D.; Vanden Berghe, W.; Dejager, L.; Libert, C.; Tavernier, J.; Beck, I.M.; De Bosscher, K. How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering. Mol. Cell. Endocrinol., 2013, 380, 41-54.
40. Thomas-Chollier, M.; Watson, L.C.; Cooper, S.B.; Pufall, M.A.; Liu, J.S.; Borzym, K.; Vingron, M.; Yamamoto, K.R.; Meijsing, S.H. A naturally occurring insertion of a single amino acid rewires transcriptional regulation by glucocorticoid receptor isoforms. Proc. Natl. Acad. Sci. USA, 2013, 110, 17826-17831.
41. Lewis-Tuffin, L.J.; Cidlowski, J.A. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann. N. Y. Acad. Sci., 2006, 1069, 1-9.
42. Kino, T.; Manoli, I.; Kelkar, S.; Wang, Y.; Su, Y.A.; Chrousos, G.P. Glucocorticoid receptor (GR) beta has intrinsic, GRalphaindependent transcriptional activity. Biochem. Biophys. Res. Commun., 2009, 381, 671-675.
43. Kino, T.; Charmandari, E.; Chrousos, G.P. Glucocorticoid receptor: implications for rheumatic diseases. Clin. Exp. Rheumatol., 2011, 29, 32-41.
44. Miller, A.L.; Webb, M.S.; Copik, A.J.; Wang, Y.; Johnson, B.H.; Kumar, R.; Thompson, E.B. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and sitespecific phosphorylation of the human glucocorticoid receptor at serine 211. Mol. Endocrinol., 2005, 19, 1569-1583.
45. Pariante, C.M.; Pearce, B.D.; Pisell, T.L.; Sanchez, C.I.; Po, C.; Su, C.; CMiller, A.H. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology, 1999, 140, 4359-4366.
46. Miller, A.H.; Pariante, C.M.; Pearce, B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv. Exp. Med. Biol., 1999, 461, 107-116.
47. Vayssičre, B.M.; Dupont, S.; Choquart, A.; Petit, F.; Garcia, T.; Marchandeau, C.; Gronemeyer, H.; Resche-Rigon, M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo. Mol. Endocrinol., 1997, 11, 1245-1255.
48. Vanden Berghe, W.; Francesconi, E.; De Bosscher, K.; Resche-Rigon, M.; Haegeman, G. Dissociated glucocorticoids with antiinflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism. Mol. Pharmacol., 1999, 56, 797-806.
49. Auphan, N.; DiDonato, J.A.; Rosette, C.; Helmberg, A.; Karin, M. Immunosupression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science, 1995, 270, 286-290.
50. De Bosscher, K.; Beck, I.M.; Dejager, L.; Bougarne, N.; Gaigneaux, A.; Chateauvieux, S.; Ratman, D.; Bracke, M.; Tavernier, J.; Vanden Berghe, W.; Libert, C.; Diederich, M.; Haegeman, G. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1. Cell. Mol. Life Sci., 2014, 71(1), 143-163.
51. Flammer, J.R.; Rogatsky, I. Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms. Mol. Endocrinol., 2011, 25, 1075-1086.
52. Stahn, C.; Löwenberg, M.; Hommes, D.W.; Buttgereit, F. Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol. Cell. Endocrinol., 2007, 15, 71-78.
53. Straub, R.H.; Buttgereit, F.; Cutolo, M. Alterations of the hypothalamic-pituitary-adrenal axis in systemic immune diseases-A role for misguided energy regulation. Clin. Exp. Rheumatol., 2011, 29(5 Suppl 68), 23-31.
54. Coutinho, A.E.; Chapman, K.E. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol. Cell. Endocrinol., 2011, 335, 2-13.
55. Hardy, R.S.; Filer, A.; Cooper, M.S.; Parsonage, G.; Raza, K.; Hardie, D.L.; Rabbitt, E.H.; Stewart, P.M.; Buckley, C.D.; Hewison, M. Differential expression, function and response to inflammatory stimuli of 11-hydroxysteroid dehydrogenase type 1 in human fibroblasts: A mechanism for tissue-specific regulation of inflammation. Arthritis Res. Ther., 2006, 8, R108.
56. Schmidt, M.; Weidler, C.; Naumann, H.; Anders, S.; Scholmerich, J.; Straub, R.H. Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system? Arthritis. Rheum., 2005, 52, 1711-1720.
57. Hardy, R.; Rabbitt, E.H.; Filer, A.; Emery, P.; Hewison, M.; Stewart, P.M.; Gittoes, N.J.; Buckley, C.D.; Raza, K.; Cooper, M.S. Local and systemic glucocorticoid metabolism in inflammatory arthritis. Ann. Rheum. Dis., 2008, 67, 1204-1210.
58. Olsen, N.; Sokka, T.; Seehorn, C.L.; Kraft, B.; Maas, K.; Moore, J.; Aune, T.M. A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. Ann. Rheum. Dis., 2004, 63, 1387-1392.
59. Haas, C.S.; Creighton, C.J.; Pi, X.; Maine, I.; Koch, A.E.; Haines, G.K.; Ling, S.; Chinnaiyan, A.M.; Holoshitz, J. Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins. Arthritis Rheum., 2006, 54, 2047-2060.
60. Onda, K.; Rimbara, E.; Hirano, T.; Oka, K.; Abe, H.; Tahara, K.; Takanashi, H.; Tsuboi, N.; Niitsuma, T.; Hayashi, T. Role of mRNA expression of transcription factors in glucocorticoid sensitivity of peripheral blood mononuclear cells and disease state in rheumatoid arthritis. J. Rheumatol., 2004, 31, 464-469.
61. Cobra, J.F.; Melo, M.R.; Faria, C.D.; Longui, C.A.; Monte, O. Simultaneous evaluation of in vivo glucocorticoid sensitivity and expression of glucocorticoid receptor alpha-isoform in rheumatoid arthritis patients. Arq. Bras. Endocrinol. Metabol., 2009, 53, 24-30.
62. Cavalcante, L.O.; Melo, M.R.; Dinis, V.G.; Castro, R.B.; Souza, B.D.; Longui, C.A. Quantitation of glucocorticoid receptor alpha and NF-κB pathway mRNA and its correlation with disease activity in rheumatoid arthritis patients. Genet. Mol. Res., 2010, 9, 2300-2310.
63. Li, X.; Zhang, F.S.; Zhang, J.H.; Wang, J.Y. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus. J. Rheumatol., 2010, 37, 316-321.
64. Melo, A.K.; Melo, M.R.; Saramago, A.B.; Demartino, G.; Souza, B.D.; Longui, C.A. Persistent glucocorticoid resistance in systemic lupus erythematosus patients during clinical remission. Genet. Mol. Res., 2013, 12, 2010-2019.
65. Ma, L.; Fang, M.; Liang, Y.; Xiang, Y.; Jia, Z.; Sun, X.; Wang, Y.; Qin, J. Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance. Ann. Hematol., 2013, 92, 953-960.
66. Hori, T.; Watanabe, K.; Miyaoka, M.; Moriyasu, F.; Onda, K.; Hirano, T.; Oka, K. Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn's disease. J. Gastroenterol. Hepatol., 2002, 17, 1070-1077.
67. Towers, R.; Naftali, T.; Gabay, G.; Carlebach, M.; Klein, A.; Novis, B. High levels of glucocorticoid receptors in patients with active Crohn's disease may predict steroid resistance. Clin. Exp. Immunol., 2005, 141, 357-362.
68. Zhang, H.; Ouyang, Q.; Wen, Z.H.; Fiocchi, C.; Liu, W.P.; Chen, D.Y.; Li, F.Y. Significance of glucocorticoid receptor expression in colonic mucosal cells of patients with ulcerative colitis. World J. Gastroenterol., 2005, 11, 1775-1778.
69. Kozaci, D.L.; Chernajovsky, Y.; Chikanza, I.C. The differential expression of corticosteroid receptor isoforms in corticosteroidresistant and-sensitive patients with rheumatoid arthritis. Rheumatology (Oxford)., 2007, 46, 579-585.
70. Chikanza, I.C. Mechanisms of corticosteroid resistance in rheumatoid arthritis: A putative role for the corticosteroid receptor beta isoform. Ann. N. Y. Acad. Sci., 2002, 966, 39-48.
71. Goecke, A.; Guerrero, J. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology, 2006, 211, 85-96.
72. Piotrowski, P.; Burzynski, M.; Lianeri, M.; Mostowska, M.; Wudarski, M.; Chwalinska-Sadowska, H.; Jagodzinski, P.P. Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem. Cytobiol., 2007, 45, 339-342.
73. Lee, C.K.; Lee, E.Y.; Cho, Y.S.; Moon, K.A.; Yoo, B.; Moon, H.B. Increased expression of glucocorticoid receptor beta messenger RNA in patients with ankylosing spondylitis. Korean J. Intern. Med., 2005, 20, 146-151.
74. Honda, M.; Orii, F.; Ayabe, T.; Imai, S.; Ashida, T.; Obara, T.; Kohg, Y. Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis. Gastroenterology, 2000, 118, 859-866.
75. Orii, F.; Ashida, T.; Nomura, M.; Maemoto, A.; Fujiki, T.; Ayabe, T.; Imai, S.; Saitoh, Y.; Kohgo, Y. Quantitative analysis for human glucocorticoid receptor alpha/beta mRNA in IBD. Biochem. Biophys. Res. Commun., 2002, 296, 1286-1294.
76. Fujishima, S.; Takeda, H.; Kawata, S.; Yamakawa, M. The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients. Clin. Immunol., 2009, 133, 208-217.
77. van Oosten, M.J.; Dolhain, R.J.; Koper, J.W.; van Rossum, E.F.; Emonts, M.; Han, K.H.; Wouters, J.M.; Hazes, J.M.; Lamberts, S.W.; Feelders, R.A. Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis. Arthritis Res. Ther., 2010, 12, R159.
78. Decorti, G.; De Iudicibus, S.; Stocco, G.; Martelossi, S.; Drigo, I.; Bartoli, F.; Ventura, A. Glucocorticoid receptor polymorphisms in inflammatory bowel disease. Gut, 2006, 55, 1053-1054.
79. De Iudicibus, S.; Stocco, G.; Martelossi, S.; Drigo, I.; Norbedo, S.; Lionetti, P.; Pozzi, E.; Barabino, A.; Decorti, G.; Bartoli, F.; Ventura, A. Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease. Gut, 2007, 56, 1319-1320.
80. van Winsen, L.M.; Hooper-van Veen, T.; van Rossum, E.F.; Koper, J.W.; Barkhof, F.; Polman, C.H.; Uitdehaag, B.M. Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS. J. Neuroimmunol., 2007, 186, 150-155.
81. Derijk, R.H.; Schaaf, M.J.; Turner, G.; Datson, N.A.; Vreugdenhil, E.; Cidlowski, J.; de Kloet, E.R.; Emery, P.; Sternberg, E.M.; Detera-Wadleigh, S.D. A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor betaisoform mRNA is associated with rheumatoid arthritis. J. Rheumatol., 2001, 28, 2383-2388.
82. Anatoniv, T.T.; Ivsahkiv, L.B. Dysregulation if interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages. Arthritis Reum., 2006, 54, 2711-2721.